OMEEBEST-D CAP S/ST
— Product

OMEEBEST-D CAP S/ST

OMEPRAZOLE 20MG + DOMPERIDONE 10MG

OMEEBEST-D CAP S/ST is a capsule combining omeprazole 20 mg with domperidone 10 mg, pairing a proton pump inhibitor with a prokinetic. It is used for gastro-oesophageal reflux, acid dyspepsia and reflux accompanied by nausea, bloating or a sensation of fullness.

01

Benefits

  • Omeprazole blocks the gastric proton pump, producing sustained acid suppression that heals oesophagitis and relieves reflux.
  • Domperidone increases gastric emptying and lower oesophageal sphincter tone, reducing the reflux itself rather than only its acidity.
  • The prokinetic action relieves the nausea, bloating and early fullness that acid suppression alone does not address.
  • Particularly useful in reflux associated with delayed gastric emptying, including diabetic gastroparesis.
  • One capsule replaces two separate medicines.
02

Side effects

Not everyone gets these. Most are mild and settle as the course finishes.

Common
  • Headache
  • Diarrhoea or constipation
  • Abdominal pain or flatulence
  • Dry mouth
Less common
  • Nausea or dizziness
  • Breast tenderness or enlargement, and milk secretion, from raised prolactin
  • Menstrual irregularity
  • Skin rash
Stop and get medical help if any of these occur
  • Palpitations, fainting or an irregular heartbeat
  • Muscle stiffness, tremor, restlessness or involuntary movements
  • Severe or persistent diarrhoea
  • Severe muscle cramps, weakness or confusion, which may indicate low magnesium
  • Black or tarry stools, or vomiting of blood
03

Precautions

  • Domperidone prolongs the QT interval and has been associated with serious arrhythmia and sudden cardiac death. Contraindicated in known QT prolongation, electrolyte disturbance and underlying cardiac disease; use at the lowest effective dose for no more than about a week.
  • Contraindicated alongside other QT-prolonging drugs and strong CYP3A4 inhibitors including ketoconazole, erythromycin and clarithromycin.
  • Contraindicated in gastrointestinal haemorrhage, mechanical obstruction or perforation, and in prolactin-releasing pituitary tumour.
  • Take thirty to sixty minutes before food; a proton pump inhibitor taken after a meal is substantially less effective.
  • Long-term proton pump inhibitor use is associated with low magnesium and vitamin B12, fracture risk and enteric infection. Review the need periodically.
  • Omeprazole reduces the effect of clopidogrel — discuss an alternative in patients on it.
  • Alarm features — weight loss, difficulty swallowing, vomiting blood, black stools, anaemia — need investigation before starting acid suppression.